Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC
Clinical trial NCT03402464 · UNKNOWN
Trial details
- NCT number
- NCT03402464
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.